Medoxem (Cefuroxime Sodium)

Cefuroxime sodium is indicated for bacterial infections affecting various organ systems and is administered by injection.

• Respiratory tract infections: effective against common pathogens causing community‑acquired pneumonia and bronchitis.
• Urinary tract infections: treats uncomplicated and complicated infections caused by susceptible bacteria.
• Skin and soft‑tissue infections: resolves cellulitis, abscesses, and wound infections.
• Meningitis: provides bactericidal activity against causative organisms in acute bacterial meningitis.
• Gonorrhoea: used for uncomplicated gonococcal infections caused by susceptible strains.

• Cefuroxime sodium inhibits bacterial cell‑wall synthesis by binding to penicillin‑binding proteins (PBPs) on the bacterial membrane. This binding interferes with the cross‑linking of peptidoglycan strands, weakening the cell wall and leading to osmotic lysis. The drug exhibits bactericidal activity against a broad spectrum of gram‑positive and gram‑negative organisms.

Cefuroxime sodium may cause a range of adverse reactions, from mild to severe.

Common Side Effects

• Injection site pain: local discomfort at the site of administration.
• Diarrhoea: loose stools that may be mild to moderate.
• Nausea: feeling of queasiness often without vomiting.
• Rash: mild skin erythema or itching.

Serious or Rare Side Effects

• Anaphylaxis: severe, potentially life‑threatening allergic reaction.
• Stevens‑Johnson syndrome: rare severe skin and mucous membrane disorder.
• Clostridioides difficile‑associated colitis: severe intestinal inflammation.
• Hemolytic anemia: destruction of red blood cells leading to anemia.

Before using Cefuroxime sodium, consider the following safety measures.

• Allergy assessment: verify no known hypersensitivity to cephalosporins or penicillins.
• Renal function monitoring: evaluate kidney function, especially in patients with impairment.
• Dose adjustment: modify dosage in patients with reduced renal clearance.
• History of colitis: use with caution in individuals with prior C. difficile infection.
• Concomitant nephrotoxins: avoid or monitor when combined with other kidney‑affecting drugs.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Cefuroxime sodium can interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid)

• Probenecid: reduces renal excretion, increasing cefuroxime levels.
• Live vaccines: may diminish vaccine efficacy or increase infection risk.
• Warfarin: potentiates anticoagulant effect, raising bleeding risk.
• Aminoglycosides: additive nephrotoxicity when used together.

Moderate Interactions (Monitor Closely)

• Diuretics: may affect renal clearance of cefuroxime.
• Oral contraceptives: possible reduction in contraceptive effectiveness.
• Antacids containing aluminium or magnesium: may alter absorption if oral formulation were used.